Posts found in:
Ian Kuliasha

KO Client Stage Closes Fund II to Support Early-Stage Companies
- KO Firm
- |
- July 27, 2023
KO client Stage, a majority female-led private equity group, recently announced the closing of its Fund II. Stage’s mission is to provide an alternative path for early-stage startups and founders, particularly post-Series A. Stage integrates venture capital, private equity, and venture studio model best practices to enable portfolio companies to…

KO Client Ascent Technology’s SATED Product Named Finalist for NASA Challenge
- KO Firm
- |
- February 27, 2023
NASA recently named KO client Ascent Technology’s SATED product as a finalist for the Deep Space Food Challenge, a public competition to extend the limits of humans in space through food. Boulder-based SATED – which stands for Safe Appliance, Tidy, Efficient, & Delicious – creates a variety of well-known foods…

KO Pro Bono Client PEBC Closes Groundbreaking $1.4 Million Financing
- KO Firm
- |
- October 26, 2022
KO pro bono client Public Education & Business Coalition (PEBC), a Denver-based national education nonprofit, recently closed on a groundbreaking $1.4 million financing to scale its Teacher Residency program. The first-of-its-kind PEBC Teacher Residency Pay for Success (PFS) initiative, coupled with complimentary funding from the Colorado Department of Education, will…

KO Client Hope Foods LLC Sold to French Dairy Firm SAVENCIA Fromage & Dairy
- KO Firm
- |
- October 26, 2021
Hope Foods LLC, a leading brand of hummus and other plant-based dips, has been acquired French dairy firm SAVENCIA Fromage & Dairy. The KO team, led by attorney Ian Kuliasha and partner Jennifer Rosenthal, represented Hope Foods in the acquisition. The acquisition includes Hope Foods’ manufacturing plant in Louisville, Colo.…

KO Pharmacology Research and Drug Discovery Client Plato BioPharma, Inc. Acquired by Inotiv, Inc.
- KO Firm
- |
- October 26, 2021
KO Client Plato BioPharma, Inc., a Colorado-based pharmacology research and drug discovery company, has been acquired by leading contract research organization Inotiv, Inc. The KO team, led by partner John Gaddis, represented Plato BioPharma in the acquisition. Plato BioPharma specializes in cardiovascular, renal, pulmonary and hepatic therapeutic areas, specifically within…

KO Client Nanospectra Closes $3 Million Series B-1 Financing
- KO Firm
- |
- September 24, 2020
KO client Nanospectra Biosciences, a medical device company that is pioneering a novel use of nanomedicine to destroy tumors without damaging adjacent healthy tissue, recently closed a $3 million Series B-1 financing with total approved capital of up to $6 million. The financing will be used for additional development and…

KO Client Company Six Raised Additional $1.5 Million
- KO Firm
- |
- August 20, 2020
KO client Company Six, a public safety robotics company, recently raised an additional $1.5 million in equity funding. This financing follows Company Six’s spin off from Sphero and $3 million seed round in May. Company Six creates robotic systems designed for first responders, defense workers and others with dangerous jobs.…

KO Client Company Six Spins Off from Sphero and Secures Financing
- KO Firm
- |
- May 26, 2020
KO client Company Six recently completed a spin off from Sphero and closed a $3 million seed round. Company Six will create robotic systems designed for first responders, defense workers and others with dangerous jobs. KO represented Company Six in the spin-off and the financing. The KO team was led…
- 1
- 2